  | Baccus, L., Dheur, A., Salmon, A., Delbecque, K., Goffin, F., De Cuypere, M., PLEYERS, C., Lovinfosse, P., Danthine, D., THILLE, A., Gonne, E., Gennigens, C., Kridelka, F., & Kakkos, A. (2024). 414 Potential association between quantified LVSI status and molecular profile in predicting nodal metastases for patient suffering early-stage endometrial cancer. International Journal of Gynecological Cancer, 34, 177-A178.  Peer Reviewed verified by ORBi |
  | Lucia, F., Bourbonne, V., PLEYERS, C., Dupré, P.-F., Miranda, O., Visvikis, D., Pradier, O., Abgral, R., Mervoyer, A., Classe, J.-M., Rousseau, C., Vos, W., HERMESSE, J., Gennigens, C., De Cuypere, M., Kridelka, F., Schick, U., Hatt, M., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06180-w Peer Reviewed verified by ORBi |
 | DHEUR, A., Salmon, A., Streel, S., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (February 2023). p53 status : a strong negative prognostic factor in endometrial carcinoma [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium. Peer reviewed |
 | Salmon, A., Streel, S., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2023). Agreement between immunohistochemistry and molecular techniques to assess microsatellite instability and p53 status in endometrial cancer [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium. Peer reviewed |
 | HERMESSE, J., PLEYERS, C., Gennigens, C., De Cuypere, M., Lovinfosse, P., Seidel, L., Coucke, P., & Kridelka, F. (2023). Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis. Strahlentherapie und Onkologie. doi:10.1007/s00066-022-01982-7 Peer Reviewed verified by ORBi |
 | Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203 Peer reviewed |
 | Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264 Peer reviewed |
 | DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States. Peer reviewed |
 | Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States. Peer reviewed |
 | Gennigens, C., Jerusalem, G., LAPAILLE, L., De Cuypere, M., Streel, S., Kridelka, F., & Ray-Coquard, I. (09 September 2022). Recurrent or primary metastatic cervical cancer: current and future treatments. ESMO Open, 7 (5), 1-3. doi:10.1016/j.esmoop.2022.100579 Peer Reviewed verified by ORBi |
 | De Cuypere, M., PLEYERS, C., HERMESSE, J., Lovinfosse, P., Delbecque, K., Gonne, E., Kakkos, A., Goffin, F., Kridelka, F., & Gennigens, C. (2022). A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study [Poster presentation]. 23rd European Congress on Gynecological Oncology, Berlin, Germany. Peer reviewed |
 | Gennigens, C., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., Seidel, L., Streel, S., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Salmon, A. (2022). 2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular analysis ? International Journal of Gynecological Cancer. doi:10.1136/ijgc-2022-ESGO.266 Peer Reviewed verified by ORBi |
 | Daix, M., Angeles, M. A., Migliorelli, F., Kakkos, A., Martinez Gomez, C., Delbecque, K., Mery, E., Tock, S., Gabiache, E., De Cuypere, M., Goffin, F., Martinez, A., Ferron, G., & Kridelka, F. (July 2021). Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer. Journal of Gynecologic Oncology, 32 (4), 48. doi:10.3802/jgo.2021.32.e48 Peer Reviewed verified by ORBi |
 | LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514. Peer reviewed |
 | GENNIGENS, C., DE CUYPERE, M., HERMESSE, J., KRIDELKA, F., & JERUSALEM, G. (2021). Optimal treatment in locally advanced cervical cancer. Expert Review of Anticancer Therapy, 657-671. doi:10.1080/14737140.2021.1879646 Peer Reviewed verified by ORBi |
 | Iantsen, A., Da Silva Ferreira, M., Lucia, F., Jaouen, V., Reinhold, C., Bonaffini, P., Alfieri, J., Rovira, R., Masson, I., Robin, P., Mervoyer, A., Rousseau, C., Kridelka, F., DE CUYPERE, M., LOVINFOSSE, P., Pradier, O., Hustinx, R., Schick, U., Visvikis, D., & Hatt, M. (2021). Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05244-z Peer Reviewed verified by ORBi |
 | Da Silva Ferreira, M., LOVINFOSSE, P., HERMESSE, J., DE CUYPERE, M., Rousseau, C., Lucia, F., Schick, U., Reinhold, C., Robin, P., Hatt, M., Visvikis, D., Bernard, C., Leijenaar, R. T. H., Kridelka, F., Lambin, P., Meyer, P., & Hustinx, R. (2021). [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05303-5 Peer Reviewed verified by ORBi |
 | GENNIGENS, C., DE CUYPERE, M., HERMESSE, J., Barbeaux, A., Forget, F., KRIDELKA, F., & JERUSALEM, G. (February 2020). Impact of hemoglobin level and red blood cell transfusions in patients with locally advanced cervical cancer treated by chemoradiotherapy [Poster presentation]. 22nd Annual BSMO meeting, Gent, Belgium. |
 | Gennigens, C., DE CUYPERE, M., SEIDEL, L., HERMESSE, J., Barbeaux, A., Forget, F., Albert, A., Jerusalem, G., & Kridelka, F. (2020). Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. Cancer Medicine, 1-12. doi:10.1002/cam4.3465 Peer Reviewed verified by ORBi |
 | Verjans, J., KRIDELKA, F., DE CUYPERE, M., & GENNIGENS, C. (2020). Locally advanced cervical cancer : a descriptive analysis of 20 patients with a visceral recurrence. European Gynecology and Obstetrics, 2 (4), 255-261. Peer reviewed |
 | DE CUYPERE, M., LOVINFOSSE, P., GOFFIN, F., Gennigens, C., Rovira, R., Duch, J., Fastrez, M., Gebhart, G., Squifflet, J. L., Luyckx, M., Charaf, G., Crener, K., Buxant, F., Bucella, D., Jouret, M., Hustinx, R., & Kridelka, F. (2020). Added value of para-aortic surgical staging compared to (18)F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. doi:10.1016/j.ejso.2019.11.496 Peer reviewed |
 | DE CUYPERE, M.* , Lovinfosse, P.* , Gennigens, C., HERMESSE, J., Rovira, R., Duch, J., GOFFIN, F., Hustinx, R., & Kridelka, F. (2020). Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer. International Journal of Gynecological Cancer, 0, 1-8. doi:10.1136/ijgc-2020-001676 Peer reviewed* These authors have contributed equally to this work. |
Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (29 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer [Paper presentation]. Bioforum Liege 2019. |
 | DE CUYPERE, M., LOVINFOSSE, P., GOFFIN, F., SCHOENEN, S., Rovira Negre, R., Duch Renom, J., Fastrez, M., Gebhart, G., Luyckx, M., Squifflet, J.-L., Charaf, G., Krener, K., Buxant, F., Bucella, D., Jouret, M., & GENNIGENS, C. (03 November 2019). Added value of para-aortic surgical staging to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer : an ONCO-GF study [Poster presentation]. ESGO 2019 Athens: 21st European Gynaecological Oncology Congress 2019, Athens, Greece. |
Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R. R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (02 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer [Paper presentation]. 2019 IEEE Nuclear Science Symposium & Medical Imaging Conference. |
Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (September 2019). Radiomics for Disease Free Survival prediction using pre-treatment FDG PET images [Paper presentation]. "Imaging of diagnostic and therapeutic biomarkers in Oncology“ workshop Manoir de Kerdréan, Le Bono, France, September 25th- 28th, 2019. |
 | GENNIGENS, C., KRIDELKA, F., JERUSALEM, G., SEIDEL, L., GOFFIN, F., Barbeaux, A., Forget, F., KAKKOS, A., HERMESSE, J., GONNE, E., & DE CUYPERE, M. (2019). Lymphocytes count at diagnosis is a potential survival predictor in patients treated by chemoradiation in locally advanced cervical cancer [Poster presentation]. ESGO 2019 Athens: 21st European Gynaecological Oncology Congress 2019, Athens, Greece. |
 | Balsat, C., Blacher, S., Herfs, M., Van De Velde, M., Signolle, N., Sauthier, P., Pottier, C., Gofflot, S., De Cuypere, M., Delvenne, P., Goffin, F., Noël, A.* , & Kridelka, F.*. (February 2017). A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer. Oncoimmunology, 6 (2), 1265718. doi:10.1080/2162402X.2016.1265718 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
KRIDELKA, F., GOFFIN, F., Leblanc, E., DE CUYPERE, M., DOYEN, J., DELBECQUE, K., KAKKOS, A., & THILLE, A. (2015). Laparoscopy and endometrial cancer. In Minimally Invasive surgery. G Smith. |
 | LAKOSI, F., DE CUYPERE, M., NGUYEN, V. P., JANSEN, N., WARLIMONT, B., GULYBAN, A., GENNIGENS, C., SEIDEL, L., DELBECQUE, K., COUCKE, P., HERMESSE, J., & KRIDELKA, F. (2015). Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience. Acta Oncologica, 54 (9), 1558-1566. doi:10.3109/0284186X.2015.1062542 Peer Reviewed verified by ORBi |
 | Doupagne, A., DE CUYPERE, M., KRIDELKA, F., GOFFIN, F., DELBECQUE, K., GENNIGENS, C., LAKOSI, F., KAKKOS, A., & HERMESSE, J. (September 2014). Parametrial boost does not replace optimal BT treatment in 102 patients with locally advanced cervical cancer (LACC) [Paper presentation]. ESGO, Torino, Italy. |
 | Ferron, G., DE CUYPERE, M., Querleu, D., & Martinez, A. (19 December 2013). Faut-il opérer un cancer du col utérin après radiochimiothérapie initiale? [Paper presentation]. SFRO (Société française de radiothérapie et d'oncologie). |
LAMBERT, M., TIMMERMANS, M., DELBECQUE, K., DE CUYPERE, M., Kridelka, F., Nisolle, M., & GOFFIN, F. (September 2013). Outcomes of women with endometrial cancer after introducing a robotics program [Poster presentation]. 10th Congress of European Society of Gynecology. |
 | Ferron, G., Luyckx, M., DE CUYPERE, M., & Martinez, A. (2013). Chimio-hyperthermie intrapéritonéale (CHIP) et cancer de l'ovaire: où en sommes-nous? Louvain Medical, 132, 8. Peer reviewed |
 | Ferron, G., Martinez, A., DE CUYPERE, M., Poilblanc, M., & Querleu, D. (2013). Utilisation de la voie laparoscopie extra-péritonéale pour la réalisation des lymphadénectomies aortiques chez des patientes obèses. e-mémoires de l'Académie Nationale de Chirurgie, 12 (3), 013. Peer Reviewed verified by ORBi |
LAMBERT, M., DELBECQUE, K., DE CUYPERE, M., TIMMERMANS, M., Nisolle, M., Kridelka, F., & GOFFIN, F. (2012). Surgical outcomes of women with endometrial cancer after introducing a robotic program [Poster presentation]. 2ème congrès ONCO-GF du GGOLFB, Bruxelles, Belgium. |
 | Martinez, A., Poilblanc, M., Ferron, G., DE CUYPERE, M., Jouve, E., & Querleu, D. (2012). Fertility-preserving surgical procedures, techniques. Best Practice and Research. Clinical Obstetrics and Gynaecology, 26, 407-424. doi:10.1016/j.bpobgyn.2012.01.009 Peer Reviewed verified by ORBi |